NCT02243150View on ClinicalTrials.gov

Safety, Pharmacokinetic and Pharmacodynamic Study of the CDK 4/6 Inhibitor G1T28-1

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

December 18, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

G1T28-1 (CDK 4/6 Inhibitor)

DRUG

Placebo

Trial Locations (1)

Unknown

PRA Early Development Clinic, Groningen

Sponsors
All Listed Sponsors
lead

G1 Therapeutics, Inc.

INDUSTRY